1. Show article details.

    BioLife Solutions Announces Closing of $86 Million Public Offering of Common Stock

    PR Newswire – 12:45 PM ET 07/07/2020

    BOTHELL, Wash. About BioLife Solutions (BLFS) BioLife Solutions (BLFS) is a leading supplier of cell and gene therapy bioproduction tools.  . View original content to download multimedia:http://www.prnewswire.com/news-releases/biolife-solutions-announces-closing-of-86-million-public-offering-of-common-stock-301089334.html. SOURCE BioLife Solutions (BLFS), Inc.

  2. Show article details.

    BRIEF-Biolife Solutions Reports Pricing Of $75 Mln Public Offering Of Common Stock

    Reuters – 8:51 AM ET 07/02/2020

    Biolife Solutions Inc (BLFS): * BIOLIFE SOLUTIONS ANNOUNCES PRICING OF $75 MILLION PUBLIC OFFERING OF COMMON STOCK. * SAYS PUBLIC OFFERING OF 5.18 MILLION COMMON SHARES PRICED AT $14.50PER SHARE Source text for Eikon: Further company coverage:

  3. Show article details.

    BioLife Solutions Announces Pricing of $75 Million Public Offering of Common Stock

    PR Newswire – 7:40 AM ET 07/02/2020

    BOTHELL, Wash. October 4, 2019, and an additional registration statement on Form S-3 to be filed with the SEC pursuant to Rule 462 under the Securities Act of 1933, as amended, which will be effective immediately upon filing.

  4. Show article details.

    BRIEF-BioLife Solutions Announces Proposed Public Offering Of Common Stock

    Reuters – 4:24 PM ET 07/01/2020

    Biolife Solutions Inc (BLFS): * BIOLIFE SOLUTIONS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage:

  5. Show article details.

    BioLife Solutions Announces $9.6 Million to $9.8 Million in Preliminary Revenue for Q2 2020

    PR Newswire – 4:02 PM ET 07/01/2020

    BOTHELL, Wash. Mike Rice, BioLife's CEO, commented, "Despite the continued impact of COVID-19 on the biotech industry and specifically, the cell and gene therapy market, we continued to drive revenue growth in the second quarter.

  6. Show article details.

    BioLife Solutions Announces Proposed Public Offering of Common Stock

    PR Newswire – 4:01 PM ET 07/01/2020

    BOTHELL, Wash. October 4, 2019. The offering will be made only by means of a written prospectus and prospectus supplement that form a part of the registration statement.

  7. Show article details.

    BioLife Solutions Promotes Marcus Schulz to Vice President, Global Sales

    PR Newswire – 4:15 PM ET 05/18/2020

    BOTHELL, Wash. August 2019 as Vice President of Sales, evo® Platform. Mike Rice, Chief Executive Officer, commented, "Marcus is a dynamic, driven, and creative senior sales leader. "On behalf of the entire BioLife team, I also want to recognize the significant contributions Jim Mathers made in building BioLife Solutions.

  8. Show article details.

    BRIEF-Biolife Solutions Reports Q1 Adjusted Earnings Per Share Of $0.06

    Reuters – 5:03 PM ET 05/14/2020

    Biolife Solutions Inc (BLFS): * BIOLIFE SOLUTIONS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS. * Q1 REVENUE ROSE 111 PERCENT TO $12.2 MILLION. * Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.06. * EARNINGS PER BASIC SHARE FOR Q1 WERE $0.87. * WITHDREW ITS FINANCIAL GUIDANCE FOR 2020. * EXECUTED A SECURITIES PURCHASE AGREEMENT WITH EXISTING SHAREHOLDER CASDIN CAPITAL.

  9. Show article details.

    BioLife Solutions Announces First Quarter 2020 Financial Results

    PR Newswire – 4:05 PM ET 05/14/2020

    BOTHELL, Wash. $12.2 million, a 111% increase over the first quarter of 2019 and a 47% increase over the fourth quarter of 2019. The Company also announced an agreement for a strategic capital investment by Casdin Capital for the purchase of $20 million of primary common shares at $10.50 per share.

  10. Show article details.

    BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020

    PR Newswire – 8:00 AM ET 05/11/2020

    BOTHELL, Wash. About BioLife Solutions (BLFS) BioLife Solutions (BLFS) is a leading supplier of cell and gene therapy bioproduction tools. Media & Investor RelationsRoderick de GreefChief Financial and Chief Operating Officer 686-6002rdegreef@biolifesolutions.com.

  11. Show article details.

    BRIEF-Biolife Solutions Says Withdrawing Financial Guidance For 2020

    Reuters – 12:23 PM ET 05/01/2020

    Biolife Solutions Inc (BLFS): * BIOLIFE SOLUTIONS ANNOUNCES PRELIMINARY FIRST QUARTER 2020 REVENUE. * Q1 REVENUE ROSE 110 PERCENT TO $12.1 MILLION. * IS WITHDRAWING FINANCIAL GUIDANCE FOR 2020 Source text for Eikon: Further company coverage:

  12. Show article details.

    BioLife Solutions Announces Preliminary First Quarter 2020 Revenue

    PR Newswire – 8:00 AM ET 05/01/2020

    BOTHELL, Wash. Preliminary Q1 2020 Revenue Total revenue for the first quarter of 2020 was $12.1 million, a 110% increase over the first quarter of 2019 and a 46% sequential increase over the fourth quarter of 2019.

Page:

Today's and Upcoming Events

  • Aug
    10

    BLFS to announce Q2 earnings (Unconfirmed)

Past Events (last 90 days)

  • May
    14

    BLFS announced Q1 earnings.

Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.